HITIQ Granted New Australian Patent
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
ASX : HIQ
4 APRIL 2024
HITIQ Granted New Australian Patent
> HITIQ has been awarded a fourth Australian Patent covering IP related to its
Nexus™ technology.
> The Patent increases protection of HITIQ’s commercial Intellectual Property (IP)
position as a leading provider of concussion management technologies.
HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a global leader in concussion management
technologies, is pleased to announce the Company has been awarded an Australian Patent, further
strengthening its IP por�olio related to its Nexus™ instrumented mouthguard head impact technology.
The Patent (No. 2020219864) “Instrumented mouthguard devices and components configured for use in
instrumented mouthguard devices,” covers the embodiment of hardware components including
accelerometer modules which enable monitoring of head movements of a mouthguard wearer.
The Company considers the Patent to be a valuable IP asset that enables sophis�cated design and
manufacturing methodologies of embedding a flexible circuit board onto a mouthguard body, allowing
for enhanced device func�on, comfort, and data quality.
HITIQ has now secured four patents in Australia that are designed to comprehensively protect the
Company’s commercial IP posi�on as a leading provider of concussion management technologies:
Australian Innovation Patent (Patent No. 2021107528) issued 7 Feb 2022 - “Technology Adapted
To Facilitate User-Specific Calibration Of Instrumented Mouthguard Devices, Including
Calibration Methods For Instrumented Mouthguard Devices";
Australian Innovation Patent (Patent No. 2021107530) issued 23 February 2022 - “A Protective
Mouthguard Device Configured To Enable Measurement Of Circulatory System Parameters”;
Australian Innovation Patent (Patent No. 20121107529) issued 18 August 2022 - “Technology
Adapted for Improved Assessment of Cognitive Function in A Human Subject, Including
Assessment of Cognitive Function Affected By Brain Injuries Sustained During Sporting
Activities”; and
Australian Patent (Patent No. 2020219864) issued 4 April 2024 - “Instrumented mouthguard
devices and components configured for use in instrumented mouthguard devices.”
HITIQ LTD
ASX:HIQ
ACN 609 543 213
Level 2, 9-17 Raglan Street South Melbourne, VIC 3205
investors@hitiq.com
www.hitiq.com
ASX ANNOUNCEMENT
HITIQ’s Nexus™ instrumented mouthguard technology is embedded in a custom fit, custom calibrated
mouthguard, and through independently validated impact sensors, captures the frequency, loca�on and
intensity of all head impact exposures. For further informa�on visit: www.hi�q.com/nexus
Commen�ng on the Patent, HITIQ Chief Execu�ve, Mike Vegar, said:
“Protecting our IP is an ongoing focus as a part of our commercial strategy that will continue to
secure our position as the global leader in concussion management technologies.
We have a pipeline of global patent initiatives across our suite of products which the Company
will develop and activate as required.”
This announcement is authorised for release by the HITIQ Board of Directors.
- Ends For more information, contact: investors@hitiq.com
About HITIQ
HITIQ has an evidenced-based brain care solution company deploying world-class technologies.
Our solutions include a sensor-enabled mouthguard to an AI-enabled data analytics interface and, best in class
return to play/work support software.
Our technology enables data driven decisions for thousands of professional and amateur sports players who
experience brain impacts, empowers clinicians who care for their brains and enhance concussion management
policies for progressive leagues around the globe.
Our customers include the Australian Football League (AFL), English Premier League (EPL), and the National Rugby
League (NRL), along with numerous other teams in a variety of sporting codes. We also service universities and
research organisations studying the impacts (both short and long-term) of repeat head impacts.
HITIQ LTD
ASX:HIQ
ACN 609 543 213
Level 2, 9-17 Raglan Street South Melbourne, VIC 3205
investors@hitiq.com
www.hitiq.com
Share your feedback
Discover